RSI and Genicon -
Imaging Technology Solutions to
Empower Biological Research

Genicon Sciences teamed with Kodak's Research Systems Inc.'s (RSI) to develop an application to identify spectral patterns from genetic material on microarrays.  These spectral patterns tell researchers the relative amounts of each specific gene within a sample as well as identify which genes are present.  The ability to identify the genetic make-up of a sample using Genicon’s Resonance Light Scattering Technology (RLS) is key in enabling Genicon Sciences’ multi-color genomic applications. 

Genicon’s RLS Technology is an ultra-sensitive signal generation and detection technology that enables the detection, measurement and analysis of a broad range of biological interactions on sample cells at the gene level.

Approximately 300,000 scientists conduct life science research globally generating 10 billion biological interactions annually. The worldwide market for biological interactions is estimated to reach $22 billion by 2005. "RSI's infoimaging software technology is a critical component of our integrated assay detection system and will play a significant role in enabling Genicon’s drive to have its RLS Technology become the "de facto" standard for detection of all biological interactions, aiding the discovery and development of new drugs," said Patrick Mallon, President & CEO, Genicon Sciences Corporation.

"Genicon was able to tap into our unique capabilities to extract specific information from an image, in this case from a microarray, to determine the genetic content of a sample.  In this particular example, the use of our spectral image processing techniques was key in providing a solution for Genicon.” - Richard Cooke, President, RSI, A Kodak Company.